{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:18:15Z","timestamp":1771474695484,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.vaccine.2010.02.089","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T09:33:27Z","timestamp":1267781607000},"page":"3333-3340","source":"Crossref","is-referenced-by-count":58,"title":["Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE"],"prefix":"10.1016","volume":"28","author":[{"given":"Joelma","family":"Trigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Abbehusen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo M.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo","family":"Pedral-Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robson Silva","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Guderian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall F.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.vaccine.2010.02.089_bib1","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2010.02.089_bib2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2010.02.089_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2010.02.089_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.vetpar.2007.07.007","article-title":"The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis","volume":"149","author":"Dantas-Torres","year":"2007","journal-title":"Vet Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.02.089_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2006.05.001","article-title":"Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine","volume":"141","author":"Dantas-Torres","year":"2006","journal-title":"Vet Parasitol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2010.02.089_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijpara.2005.07.001","article-title":"The current status of zoonotic leishmaniases and approaches to disease control","volume":"35","author":"Gramiccia","year":"2005","journal-title":"Int J Parasitol"},{"issue":"9330","key":"10.1016\/j.vaccine.2010.02.089_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0140-6736(02)09609-5","article-title":"Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial","volume":"360","author":"Gavgani","year":"2002","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2010.02.089_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1471-4922(02)02296-1","article-title":"Canine leishmaniasis: novel strategies for control","volume":"18","author":"Reithinger","year":"2002","journal-title":"Trends Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.089_bib9","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/516096","article-title":"Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil","volume":"25","author":"Dietze","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2010.02.089_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0035-9203(95)90474-3","article-title":"Visceral leishmaniasis in a new ecological niche near a major metropolitan area of Brazil","volume":"89","author":"Cunha","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.089_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0074-02762001000300002","article-title":"Visceral leishmaniasis in the metropolitan region of Belo Horizonte, State of Minas Gerais, Brazil","volume":"96","author":"Silva","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"4","key":"10.1016\/j.vaccine.2010.02.089_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","article-title":"Chemotherapy of canine leishmaniasis","volume":"106","author":"Baneth","year":"2002","journal-title":"Vet Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.089_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2010.02.089_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"Alvar","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.02.089_bib15","first-page":"231","article-title":"Canine leishmaniasis: evolution of the chemotherapeutic protocols","volume":"46","author":"Oliva","year":"2004","journal-title":"Parasitologia"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.02.089_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-4017(99)00084-9","article-title":"Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate","volume":"84","author":"Riera","year":"1999","journal-title":"Vet Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.02.089_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpara.2003.09.006","article-title":"Are insecticide-impregnated dog collars a feasible alternative to dog culling as a strategy for controlling canine visceral leishmaniasis in Brazil?","volume":"34","author":"Reithinger","year":"2004","journal-title":"Int J Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.02.089_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vetpar.2006.06.029","article-title":"Deltamethrin-impregnated collars for the control of canine leishmaniasis: evaluation of the protective effect and influence on the clinical outcome of Leishmania infection in kennelled stray dogs","volume":"142","author":"Foglia Manzillo","year":"2006","journal-title":"Vet Parasitol"},{"issue":"13","key":"10.1016\/j.vaccine.2010.02.089_bib19","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2010.02.089_bib20","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"Lemesre","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2010.02.089_bib21","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Ieishmaniasis by elicitation of CD(4+) T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2010.02.089_bib22","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.02.089_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.vaccine.2009.10.045","article-title":"Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis","volume":"28","author":"Velez","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.02.089_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14760584.2.2.239","article-title":"Development of a leishmaniasis vaccine: the importance of MPL","volume":"2","author":"Reed","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"45","key":"10.1016\/j.vaccine.2010.02.089_bib25","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2010.02.089_bib26","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.vaccine.2008.01.026","article-title":"Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f+MPL-SE vaccine to treat canine visceral leishmaniasis","volume":"26","author":"Miret","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.089_bib27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/infdis\/173.3.758","article-title":"rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis","volume":"173","author":"Badaro","year":"1996","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.089_bib28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/CVI.00420-06","article-title":"Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs","volume":"14","author":"Porrozzi","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2010.02.089_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetpar.2008.10.097","article-title":"Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs","volume":"160","author":"Goto","year":"2009","journal-title":"Vet Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.02.089_bib30","first-page":"383","article-title":"Leishmaniasis in Tuscany (Italy): VI. Canine leishmaniasis in the focus of Monte Argentario (Grosseto)","volume":"38","author":"Pozio","year":"1981","journal-title":"Acta Trop"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2010.02.089_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.vetpar.2006.08.019","article-title":"Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate","volume":"143","author":"Ikeda-Garcia","year":"2007","journal-title":"Vet Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.089_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1939-1676.1999.tb01455.x","article-title":"Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)","volume":"13","author":"Denerolle","year":"1999","journal-title":"J Vet Intern Med"},{"issue":"10","key":"10.1016\/j.vaccine.2010.02.089_bib33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (Viannia) infection","volume":"193","author":"Rojas","year":"2006","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2010.02.089_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbieri","year":"2006","journal-title":"Parasite Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.089_bib35","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/eji.1830250619","article-title":"Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner","volume":"25","author":"Pinelli","year":"1995","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.02.089_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.02.089_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vetimm.2006.10.001","article-title":"Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi","volume":"115","author":"Lage","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"issue":"11","key":"10.1016\/j.vaccine.2010.02.089_bib38","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.089_bib39","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2010.02.089_bib40","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.96.12.6970","article-title":"Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms","volume":"96","author":"Walker","year":"1999","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10002811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10002811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T22:55:11Z","timestamp":1590706511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10002811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":40,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0264410X10002811"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}